We are live on ! Find out more
HP

Hikari Power Portfolio holdings

AUM $855M
1-Year Est. Return 14.24%
This Fund
S&P 500
This Quarter Est. Return
-11%
1 Year Est. Return
+14.24%
3 Year Est. Return
+53.45%
5 Year Est. Return
+75.51%
10 Year Est. Return
+220.8%
AUM
$889M
AUM Growth
-$95.1M
Cap. Flow
+$25.1M
Cap. Flow %
2.82%
Top 10 Hldgs %
55.95%
Holding
141
New
14
Increased
27
Reduced
13
Closed
18

Top Buys

Rank Stock Value
1
LIN icon
Linde
LIN
+$23.9M
2
GE icon
GE Aerospace
GE
+$13.5M
3
BNY
Bank of New York Mellon
BNY
+$13.3M
4
MMM icon
3M
MMM
+$6.14M
5
CI icon
Cigna
CI
+$5.67M

Top Sells

Rank Stock Value
1
PX
Praxair Inc
PX
+$24.3M
2
ESRX
Express Scripts Holding Company
ESRX
+$10.6M
3
DVA icon
DaVita
DVA
+$10.5M
4
PSX icon
Phillips 66
PSX
+$9.17M
5
NOV icon
NOV
NOV
+$5.11M

Sector Composition

Rank Sector Weight
1 Financials 38.62%
2 Healthcare 19.54%
3 Industrials 11.83%
4 Consumer Staples 6.99%
5 Technology 6.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KO icon
51
Coca-Cola
KO
$372B
$2.18M 0.25%
46,000
VWO icon
52
Vanguard FTSE Emerging Markets ETF
VWO
$125B
$1.99M 0.22%
52,200
+18,000
+53% +$697K
NOV icon
53
NOV
NOV
$7.49B
$1.99M 0.22%
77,300
-147,800
-66% -$5.11M
MA icon
54
Mastercard
MA
$492B
$1.89M 0.21%
10,000
AKTX
55
Akari Therapeutics
AKTX
$13.5M
$1.88M 0.21%
1,500
+250
+20% +$366K
MCD icon
56
McDonald's
MCD
$194B
$1.79M 0.2%
10,060
JKHY icon
57
Jack Henry & Associates
JKHY
$10.9B
$1.73M 0.2%
13,700
AXP icon
58
American Express
AXP
$230B
$1.68M 0.19%
17,600
HDV
59
iShares Core High Dividend ETF
HDV
$15B
$1.56M 0.18%
92,500
STOR
60
DELISTED
STORE Capital Corporation
STOR
$1.04M 0.12%
36,700
DVAX
61
DELISTED
Dynavax Technologies
DVAX
$966K 0.11%
105,573
-50,182
-32% -$555K
ST icon
62
Sensata Technologies
ST
$6.73B
$807K 0.09%
18,000
DNOW icon
63
DNOW Inc
DNOW
$3.01B
$648K 0.07%
55,675
LRMR icon
64
Larimar Therapeutics
LRMR
$448M
$641K 0.07%
+10,793
New +$1.07M
BTI icon
65
British American Tobacco
BTI
$122B
$616K 0.07%
19,350
FSTX
66
DELISTED
F-star Therapeutics, Inc. Common Stock
FSTX
$556K 0.06%
13,384
+10,550
+372% +$474K
ALDX icon
67
Aldeyra Therapeutics
ALDX
$91.1M
$500K 0.06%
60,190
-47,668
-44% -$488K
MDR
68
DELISTED
McDermott International
MDR
$494K 0.06%
75,600
-1,038
-1% -$11K
CRVS icon
69
Corvus Pharmaceuticals
CRVS
$1.24B
$477K 0.05%
130,000
+97,910
+305% +$668K
ALPN
70
DELISTED
Alpine Immune Sciences Inc
ALPN
$453K 0.05%
+122,972
New +$607K
L icon
71
Loews
L
$23.1B
$442K 0.05%
9,700
OMC icon
72
Omnicom Group
OMC
$23.6B
$403K 0.05%
5,500
BRK.B icon
73
Berkshire Hathaway Class B
BRK.B
$1.11T
$398K 0.04%
1,950
+950
+95% +$198K
MRSN
74
DELISTED
Mersana Therapeutics
MRSN
$348K 0.04%
+3,416
New +$540K
DO
75
DELISTED
Diamond Offshore Drilling
DO
$332K 0.04%
35,200

Similar funds

Hikari Power's Q4 2018 Portfolio in Review

As of Q4 2018, Hikari Power held 141 positions worth $889M, down 9.7% from $984M the previous quarter. Its ten largest holdings account for 56% of the portfolio.

Hikari Power's Q4 2018 filing shows 14 new, 27 increased, 13 reduced and 18 closed positions. Its largest new stake was Linde: 151,020 shares worth $23.6M. The largest sale was Praxair Inc, an estimated $24.3M.

By sector, the portfolio is most concentrated in Financials at 39% of assets, up from 36% a quarter earlier, followed by Healthcare and Industrials.

  • Hikari Power's largest Q4 2018 buy was Linde: 151,020 shares worth $23.6M.
  • Hikari Power added most to GE Aerospace in Q4 2018, an estimated $13.5M increase.
  • Hikari Power's biggest Q4 2018 reduction was DaVita, cutting an estimated $10.5M.
  • Hikari Power fully exited Praxair Inc in Q4 2018, selling an estimated $24.3M.
  • Hikari Power's ten largest holdings make up 56% of its $889M portfolio in Q4 2018.
  • Hikari Power opened 14 new positions and closed 18 in Q4 2018.
  • Hikari Power's portfolio value fell 9.7% quarter-over-quarter to $889M.

Based on Hikari Power's 13F filing for Q4 2018, filed 29 Jan 2019.